Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 39.84
+0.44 (1.12%)
Jan 23, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.77 billion as of January 23, 2026. Its market cap has increased by 74.39% in one year.
Market Cap
5.77B
Enterprise Value
4.24B
Revenue
478.69M
Ranking
n/a
PE Ratio
60.30
Stock Price
39.84
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.77B, a decrease of -29.93%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 5.77B | 4.29% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaResources (Shanghai) | 6.50B |
| Jiangsu Bioperfectus Technologies | 6.48B |
| Xiangxue Pharmaceutical | 6.43B |
| Wuhan Hvsen Biotechnology | 6.35B |
| Shanghai OPM Biosciences | 6.34B |
| Novogene | 5.98B |
| Shenzhen Weiguang Biological Products | 5.93B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.75B |